Dr. Jeremy Rosenblum

MD | Pediatric Hematology-Oncology | Male

Dr. Jeremy Rosenblum, MD is a Bronx, New York based Pediatric doctor with medical specialization in Pediatric Hematology-Oncology. Current practice location of Dr. Jeremy Rosenblum is 111 E 210th St, Rosenthal 3, Bronx, New York - 10467-2401. He can be contacted on phone at 718-741-2342. Dr. Jeremy Rosenblum is a sole proprietor of his business.
NPI number (Unique professional ID) for Dr. Jeremy Rosenblum is 1982839858 which was assigned by NPPES on 21 May, 2009 and it was last updated on 21 May, 2009. Dr. Jeremy Rosenblum license number is 253164 for Pediatrics Pediatric Hematology-Oncology (2080P0207X) in New York.
Dr. Jeremy Rosenblum is trained in the combination of pediatrics, hematology and oncology to recognize and manage pediatric blood disorders and cancerous diseases.
Complete Profile:
Dr. Jeremy Rosenblum basic information including his official name, gender, specialization, credentials etc. are as mentioned below.
Specialization :Pediatrics Pediatric Hematology-Oncology
Provider Name :Dr. Jeremy Rosenblum
Credential :MD
Gender :Male
Business Address:
Dr. Jeremy Rosenblum address, contact phone number and fax are as below. Patients can directly walkin to the clinic or can call on the below given phone number for appointment.
Primary Address :111 E 210th St, Rosenthal 3
Bronx, NY, 10467-2401
United States
Phone Number :718-741-2342
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS). NPI details are as mentioned below.
NPI Number : 1982839858
NPI Entity Type : Individual
First Enrolment Date : 21 May, 2009
Last Updated On : 21 May, 2009
Medicare Participation:
Dr. Jeremy Rosenblum participates in medicare and accepts medicare insurance either directly or through association with group practice or medical facility.
Medicare PECOS ID :9638326507
Medicare Enrollment ID :I20120828000594
Primary Specialty :Hematology/oncology
Medical School :Albert Einstein College Of Medicine Of Yeshiva University
Graduation Year :2006
Accepts Medicare?Yes. Dr. Jeremy Rosenblum accepts medicare insurance.
Group Practice Association:
Dr. Jeremy Rosenblum is associated with following Group Practice Organizations. Group practices are practice of medicine by a group of physicians who share their premises and other resources. Following list states all the group name with which Dr. Jeremy Rosenblum is associated with along with the number of members in that group. He may also accept medicare indirectly via these group practices.
Organisation Name :Group Practice IDNo. of MembersPractice AddressGroup Accepts Medicare
Boston Children's Health Physicians Llp83259370146119 Bradhurst Ave
Hawthorne, NY - 105322140
Ph: 9144937235
Yes
Boston Children's Health Physicians Llp83259370146119 Bradhurst Ave
Suite 200n
Hawthorne, NY - 105322140
Ph: 9144937701
Yes
Boston Children's Health Physicians Llp83259370146195 Grasslands Rd
Valhalla, NY - 105951652
Ph: 9145942387
Yes
Licenses and Specialities:
Physicians/Organizations can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Dr. Jeremy Rosenblum are as mentioned. Primary taxonomy code for Dr. Jeremy Rosenblum, MD is 2080P0207X (Pediatrics Pediatric Hematology-Oncology).
Taxonomy Code SpecialityPrimaryLicense No.State
2080P0207XPediatrics Pediatric Hematology-OncologyYes253164NY
Mailing Address:
Mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned business address only.
Mailing Address :111 E 210th St, Rosenthal 3
Bronx, NY, 10467-2401
United States
Business Location:
Patients can refer following map for directions to Dr. Jeremy Rosenblum practice address. Don't forget to take prior appointment before visiting.

** Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 08 January, 2024.